Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Schade van Westrum, Steven ^a,d   Dekker, Lukas ^a,e   de Haan, Rob ^a   Endert, Erik ^b   Ginjaar, Ieke ^c   de Visser, Marianne ^a   van der Kooi, Anneke ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MARTINI HOSPITAL   (Netherlands)

^e CATHARINA HOSPITAL   (Netherlands)

Author keywords

Becker muscular dystrophy; Brain Natriuretic peptide; Dilated cardiomyopathy; Duchenne muscular dystrophy; Dystrophinopathy carriers

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DYSTROPHIN;

ADOLESCENT; ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHILD; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, DILATED; CHILD; COHORT STUDIES; DYSTROPHIN; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MIDDLE AGED; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; ROC CURVE; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84880089580     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-88     Document Type: Article

References (27)

1. Kirchmann C, Kececioglu D, Korinthenberg R, Dittrich S. Echocardiographic and Electrocardiographic Findings of Cardiomyopathy in Duchenne and Becker?Kiener Muscular Dystrophies. Pediatr Cardiol 2005, 26:66-72. 10.1007/s00246-004-0689-2, 15793655.
2. Nigro G, Comi LI, Politano L, Bain RJ. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990, 26:271-277. 10.1016/0167-5273(90)90082-G, 2312196.
3. Nigro G, Comi LI, Politano L, Limongelli FM, Nigro V, De Rimini ML, Giugliano MA, Petretta VR, Passamano L, Restucci B. Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve 1995, 18:283-291. 10.1002/mus.880180304, 7870105.
4. Hoogerwaard EM, de Voogt WG, Wilde AA, van der Wouw PA, Bakker E, van Ommen GJ, de Visser M. Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period. J Neurol 1997, 244:657-663. 10.1007/s004150050163, 9402544.
5. Melacini P, Fanin M, Danieli G, Villanova C. Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 1996, 94:3168-3175. 10.1161/01.CIR.94.12.3168, 8989125.
6. Hoogerwaard EM, van der Wouw PA, Wilde AA, Bakker E, Ippel PF, Oosterwijk JC, Majoor-Krakauer DF, van Essen AJ, Leschot NJ, de Visser M. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 1999, 9:347-351. 10.1016/S0960-8966(99)00018-8, 10407858.
7. Grain L, Cortina-Borja M, Forfar C, Hilton-Jones D, Hopkin J, Burch M. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls. Neuromuscul Disord 2001, 11:186-191. 10.1016/S0960-8966(00)00185-1, 11257476.
8. Politano L, Nigro V, Nigro G. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 1996, 275:1335-1338. 10.1001/jama.1996.03530410049032, 8614119.
9. Maisel A, Mueller C, Adams K, Anker SD, Aspromonte N, Cleland JGF, Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Filippatos GS, Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K, Mebazaa A, Nieminen MS, Peacock WF, Tubaro M, Valle R, Vanderhyden M, Yancy CW, Zannad F, Braunwald E. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008, 10:824-839. 10.1016/j.ejheart.2008.07.014, 18760965.
10. Mori K, Manabe T, Nii M, Hayabuchi Y, Kuroda Y, Tatara K. Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy. Pediatr Cardiol 2002, 23:160-166. 10.1007/s00246-001-0040-0, 11889527.
11. van Bockel EAP, Lind JS, Zijlstra JG, Wijkstra PJ, Meijer PM, van den Berg MP, Slart RHJA, Aarts LPHJ, Tulleken JE. Cardiac assessment of patients with late stage Duchenne muscular dystrophy. Neth Heart J 2009, 17:232-237. 10.1007/BF03086253, 2711248, 19789685.
12. Brooke M, Fenichel G, Griggs R, Mendell J. Duchenne muscular dystrophy. Neurology 1989, 39:475-481. 10.1212/WNL.39.4.475, 2927672.
13. Deutsch HJ, Curtius JM, Leischik R, Sechtem U, Maschler C, de Vivie ER, Hilger HH. Reproducibility of assessment of left-ventricular function using intraoperative transesophageal echocardiography. Thorac Cardiovasc Surg 1993, 41:54-58. 10.1055/s-2007-1013821, 8367857.
14. Silcocks PB, Munro JF, Steeds RP, Channer KS. Prognostic implications of qualitative assessment of left ventricular function compared to simple routine quantitative echocardiography. Heart 1997, 78:237-242. 484924, 9391284.
15. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1980, 62:1054-1061. 10.1161/01.CIR.62.5.1054, 7418156.
16. Who ISFCTF. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980, 44:672-673. 482464, 7459150.
17. Authors/Task Force Members The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 2005(26):1115-1140. Authors/Task Force Members.
18. Kashiwagi S, Akaike M, Kawai H. Estimation of cardiac function by plasma concentration of brain natriuretic peptide in patients with Duchenne muscular dystrophy. Rinsho Shinkeigaku 1996, 36:7-11. abstract.
19. Demachi J, Kagaya Y, Watanabe J, Sakuma M, Ikeda J, Kakuta Y, Motoyoshi I, Kohnosu T, Sakuma H, Shimazaki S, Sakai H, Kimpara T, Takahashi T, Omura K, Okada M, Saito H, Shirato K. Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy. Neuromusc Dis 2004, 14:732-739. 10.1016/j.nmd.2004.08.002, 15482958.
20. Adachi K, Kawai H, Saito M, Naruo T, Kimura C, Mine H, Inui T, Kashiwagi S, Akaike M. Plasma levels of brain natriuretic peptide as an index for evaluation of cardiac function in female gene carriers of Duchenne muscular dystrophy. Intern Med 1997, 36:497-500. 10.2169/internalmedicine.36.497, 9240500.
21. Mohyuddin T, Jacobs IB, Bahler RC. B-type natriuretic peptide and cardiac dysfunction in Duchenne muscular dystrophy. Int J Cardiol 2007, 119:389-391. 10.1016/j.ijcard.2006.07.163, 17079036.
22. Duboc D, Meune C, Lerebours G, Devaux J-Y, Vaksmann G, Bécane H-M. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 2005, 45:855-857. 10.1016/j.jacc.2004.09.078, 15766818.
23. Silversides C. Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy. Am J Cardiol 2003, 91:769-772. 10.1016/S0002-9149(02)03429-X, 12633823.
24. Kajimoto H, Ishigaki K, Okumura K, Tomimatsu H, Nakazawa M, Saito K, Osawa M, Nakanishi T. Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. Circ J 2006, 70:991-994. 10.1253/circj.70.991, 16864930.
25. Ramaciotti C, Scott WA, Lemler MS, Haverland C, Iannaccone ST. Assessment of Cardiac Function in Adolescents With Duchenne Muscular Dystrophy: Importance of Neurohormones. J Child Neurol 2002, 17:191-194. 10.1177/088307380201700307, 12026234.
26. Gackowski A, Isnard R, Golmard J-L, Pousset F, Carayon A, Montalescot G, Hulot J-S, Thomas D, Piwowarska W, Komajda M. Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur Heart J 2004, 25:1788-1796. 10.1016/j.ehj.2004.07.038, 15474693.
27. Taniguchi R, Sato Y, Nishio Y, Kimura T, Kita T. Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies. Hear Vessel 2006, 21:344-349.